Recruiting studies: Multiomics

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Multiomics Tumor Evolution Model of NSCLC
Phase N/A · 1 location(s) · Peking University People's Hospital · NCT05352035 Cerebral Large Vessel Occlusion Stroke Multiomics Biosample Cohort
Phase N/A · 5 location(s) · First Affiliated Hospital of Wannan Medical College · NCT06963489 Integration of Multiomics Markers for Invasive IPMNs Identification Through the Set-up of the INvasive Cyst bIomarkers D
Phase N/A · 1 location(s) · IRCCS San Raffaele · NCT06694792 Assesment of Multiomics Profiles in Health and Disease.
Phase N/A · 1 location(s) · The Institute of Molecular and Translational Medicine, Czech · NCT04427163 Molecularly Aided Stratification for Tumor Eradication Research
Phase N/A · 1 location(s) · German Cancer Research Center · NCT05852522 Early Evaluation of Exosome Multiomics and Clinical Prognosis in Patients With Sudden Death
Phase N/A · 1 location(s) · The Affiliated Nanjing Drum Tower Hospital of Nanjing Univer · NCT06856993 The EpiGASTRIC/EDGAR Project: New Strategies for the Early Detection and Prevention of Gastric Cancer
Phase N/A · 15 location(s) · EDUARDO ALBENIZ · NCT05551416 Omics-driven Research on the Gut-Oral Microbiome, Metabolome, Lifestyle, and Clinical Integration in Korean Inflammatory
Phase N/A · 1 location(s) · Chang Kyun Lee · NCT06124833 Identifying Predictors Of Response To Mepolizumab In CRSwNP
Phase 4 · 1 location(s) · Centre hospitalier de l'Université de Montréal (CHUM) · NCT05902325 Hereditary Ataxia Research on Multi-Omics and Neuroclinical Insights in the Yangtze Delta
Phase N/A · 2 location(s) · Second Affiliated Hospital, School of Medicine, Zhejiang Uni · NCT07092358 Accurate Assessment and Intervention Research on Newborn Whole Genome Sequencing and Genetic Disease Risk
Phase N/A · 1 location(s) · Women's Hospital School Of Medicine Zhejiang University · NCT07365254 A Real-world Study of the Efficacy and Safety of ICIs as First-line Therapy for Advanced Malignancies
Phase N/A · 1 location(s) · Xinqiao Hospital of Chongqing · NCT05862259 Clinical Validation of Freenome Multiomics Blood Test for Lung Cancer Screening
Phase N/A · 36 location(s) · Freenome Holdings Inc. · NCT06122077 Emergency PWAS in Respiratory Infectious Disease
Phase N/A · 1 location(s) · The University of Hong Kong · NCT05336851 Stopping Cognitive Decline and Dementia by Fighting Covert Cerebral Small Vessel Disease
NA · 2 location(s) · University Hospital, Bordeaux · NCT05306834 Risk Factors and Multiomics Study of Chronic Kidney Disease Caused by Metabolic Diseases
Phase N/A · 1 location(s) · Peking Union Medical College Hospital · NCT05476627 Prediction of LVAR and MACE in STEMI Though Plasma Multiomics Analysis
Phase N/A · 1 location(s) · Beijing Anzhen Hospital · NCT06885619 MSC Exosome Therapy for Post-Preeclampsia Endothelial Dysfunction
Phase 1/Phase 2 · 1 location(s) · Universitas Padjadjaran · NCT07183384 Prediction Model for Response to Biologics and Small Molecular Agent for UC
Phase N/A · 1 location(s) · Asan Medical Center · NCT05186623 Multiomics Biomarkers for Urolithiasis
Phase N/A · 1 location(s) · Chinese University of Hong Kong · NCT05452291 BALance: ARDS Deconvolution by Bronchoalveolar Lavage Multiomics and Radiomics
Phase N/A · 1 location(s) · Medical University of Vienna · NCT07633366 Monitoring Drug Efficacy in Patients with Alzheimer's Disease
Phase N/A · 1 location(s) · University of the Philippines · NCT05801380 Multiomics Approach in Adult Patients With Phenylketonuria
Phase N/A · 15 location(s) · University Hospital, Tours · NCT07484945 Single-cell Multiomics and Spatiotemporal Omics Analyze the Mechanism of Liver Degenerative Disease
Phase N/A · 1 location(s) · Nanfang Hospital, Southern Medical University · NCT07265544 Predicting Responsiveness in Oncology Patients Based on Host Response Evaluation During Anti Cancer Treatments, Using Mu
Phase N/A · 1 location(s) · OncoHost Ltd. · NCT05736029 Predictive Biomarkers of Response to Checkpoint Inhibitors in Triple Negative Breast Cancer: a Multiomics Platform
Phase N/A · 1 location(s) · Vall d'Hebron Institute of Oncology · NCT05916755 Using Multiomics to Define Mechanisms of Rhinovirus-induced Chronic Obstructive Pulmonary Disease Exacerbations to Devel
Phase N/A · 1 location(s) · Imperial College London · NCT07112235 AI-Assisted System for Accurate Diagnosis and Prognosis of Breast Phyllodes Tumors
Phase N/A · 4 location(s) · Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University · NCT06286267 A.I and Machine Learning Based Risk Prediction Model to Improve the Clinical Management of Endometrial Cancer.
Phase N/A · 1 location(s) · Regina Elena Cancer Institute · NCT06841653 Deep, Multi-omics Phenotyping to Predict Response, Resistance and Recurrence to Adjuvant Atezolizumab Plus Bevacizumab i
Phase 2 · 6 location(s) · National Cancer Centre, Singapore · NCT05516628

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.